Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis Type 1: Clinical article

Journal of Neurosurgery

Volumn 118, Issue 1, 2013, Pages 142-148

  Dunn, Gavin P ^a   Spiliopoulos, Konstantinos ^a   Plotkin, Scott R ^a   Hornicek, Francis J ^a   Harmon, David C ^a   Delaney, Thomas F ^a   Williams, Ziv ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Malignancy; Neurofibromatosis; Peripheral nerve; Peripheral nerve sheath tumor

Indexed keywords

CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; MESNA; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LOCAL RECURRENCE FREE SURVIVAL; MALE; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MEDICAL RECORD REVIEW; METASTASIS; NERVE SURGERY; NEUROFIBROMATOSIS; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL MORTALITY; TUMOR LOCALIZATION; TUMOR VOLUME; WEAKNESS;

ADULT; AGED; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NERVE SHEATH NEOPLASMS; NEUROFIBROMATOSIS 1; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84872199369     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2012.9.JNS101610     Document Type: Article

References (29)

1. Anghileri M, Miceli R, Fiore M, Mariani L, Ferrari A, Mussi C, et al: Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution. Cancer 107:1065-1074, 2006
2. Baehring JM, Betensky RA, Batchelor TT: Malignant peripheral nerve sheath tumor: the clinical spectrum and outcome of treatment. Neurology 61:696-698, 2003
3. Bhattacharyya AK, Perrin R, Guha A: Peripheral nerve tumors: management strategies and molecular insights. J Neurooncol 69:335-349, 2004
4. Bhola P, Banerjee S, Mukherjee J, Balasubramanium A, Arun V, Karim Z, et al: Preclinical in vivo evaluation of rapamycin in human malignant peripheral nerve sheath explant xenograft. Int J Cancer 126:563-571, 2010
5. Cashen DV, Parisien RC, Raskin K, Hornicek FJ, Gebhardt MC, Mankin HJ: Survival data for patients with malignant schwannoma. Clin Orthop Relat Res 426:69-73, 2004
6. De Raedt T, Brems H, Wolkenstein P, Vidaud D, Pilotti S, Perrone F, et al: Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet 72:1288-1292, 2003
7. DeLaney TF, Spiro IJ, Suit HD, Gebhardt MC, Hornicek FJ, Mankin HJ, et al: Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys 56:1117-1127, 2003
8. Doorn PF, Molenaar WM, Buter J, Hoekstra HJ: Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur J Surg Oncol 21:78-82, 1995
9. Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM: Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 57:2006-2021, 1986
10. Ferner RE, Gutmann DH: International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 62:1573-1577, 2002
11. Gachiani J, Kim D, Nelson A, Kline D: Surgical management of malignant peripheral nerve sheath tumors. Neurosurg Focus 22(6):E13, 2007
12. Gieschen HL, Spiro IJ, Suit HD, Ott MJ, Rattner DW, Ancukiewicz M, et al: Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys 50:127-131, 2001
13. Grobmyer SR, Reith JD, Shahlaee A, Bush CH, Hochwald SN: Malignant peripheral nerve sheath tumor: molecular pathogenesis and current management considerations. J Surg Oncol 97:340-349, 2008
14. Gupta G, Maniker A: Malignant peripheral nerve sheath tumors. Neurosurg Focus 22(6):E12, 2007
15. Harrison LB, Franzese F, Gaynor JJ, Brennan MF: Long-term results of a prospective randomized trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys 27:259-265, 1993
16. Jeyaretna DS, Rabkin SD, Martuza RL: Oncolytic herpes simplex virus therapy for peripheral nerve tumors. Neurosurg Focus 22(6):E4, 2007
17. Johannessen CM, Reczek EE, James MF, Brems H, Legius E, Cichowski K: The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc Natl Acad Sci U S A 102:8573-8578, 2005
18. Kar M, Deo SV, Shukla NK, Malik A, DattaGupta S, Mohanti BK, et al: Malignant peripheral nerve sheath tumors (MPNST) - clinicopathological study and treatment outcome of twenty-four cases. World J Surg Oncol 4:55, 2006
19. Kraybill WG, Harris J, Spiro IJ, Ettinger DS, DeLaney TF, Blum RH, et al: Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514. J Clin Oncol 24:619-625, 2006
20. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109, 2007
21. O'Sullivan B, Davis AM, Turcotte R, Bell R, Catton C, Chabot P, et al: Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 359:2235-2241, 2002
22. Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M: A systemic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 113:573-581, 2008
23. Porter DE, Prasad V, Foster L, Dall GF, Birch R, Grimer RJ: Survival in malignant peripheral nerve sheath tumours: a comparison between sporadic and neurofibromatosis type 1-associated tumours. Sarcoma 2009:756395, 2009
24. Sarcoma Meta-analysis Collaboration: Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet 350:1647-1654, 1997
25. Sordillo PP, Helson L, Hajdu SI, Magill GB, Kosloff C, Golbey RB, et al: Malignant schwannoma - clinical characteristics, survival, and response to therapy. Cancer 47:2503-2509, 1981
26. Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, de Mascarel A, et al: Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 33:37-42, 1984
27. Wanebo JE, Malik JM, VandenBerg SR, Wanebo HJ, Driesen N, Persing JA: Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer 71:1247-1253, 1993
28. Wong WW, Hirose T, Scheithauer BW, Schild SE, Gunderson LL: Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys 42:351-360, 1998
29. Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, et al: Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 16:197-203, 1998